A recent study on genomically characterized patient-derived xenografts (PDX) observed increases in PSMA and androgen receptor (AR) mRNA as well as tumor microdensity after ADT in castration-sensitive models [21]. This evidence concerns the gene FOLH1 and neoplasm.